Targeting the Bcl-2 family for cancer therapy

Author： Thomas Shibu   Quinn Bridget A   Das Swadesh K   Dash Rupesh   Emdad Luni   Dasgupta Santanu   Wang Xiang-Yang   Dent Paul   Reed John C   Pellecchia Maurizio   Sarkar Devanand   Fisher Paul B  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.1, 2013-01, pp. : 61-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy

By  

Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-11 ,pp. : 244-254

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues

By  

Current Medicinal Chemistry, Vol. 20, Iss. 24, 2013-08 ,pp. : 2964-2978

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the BCL-2 family in malignancies of germinal centre origin

By Spender Lindsay C   Inman Gareth J  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 12, 2009-12 ,pp. : 1459-1472

Informa Healthcare

Access to resources Recommend Favorite

Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. : 1804-1820

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Bcl-2 in CLL

By  

Current Medicinal Chemistry, Vol. 19, Iss. 30, 2012-10 ,pp. : 5109-5115

Bentham Science Publishers

Access to resources Recommend Favorite